In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries

International Journal of Antimicrobial Agents

Volumn 28, Issue 1, 2006, Pages 14-18

  Lee, Mi Young ^a   Ko, Kwan Soo ^a,b   Oh, Won Sup ^b   Park, Sulhee ^a   Lee, Ji Young ^a   Baek, Jin Yang ^a   Suh, Ji Yoeun ^a   Peck, Kyong Ran ^b   Lee, Nam Yong ^b   Song, Jae Hoon ^a,b  

^a Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Antimicrobial resistance; Cefditoren; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFDINIR; CEFDITOREN; CEFIXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN G; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ASIA; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIZATION; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; INCIDENCE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; ASIA; CEPHALOSPORINS; HAEMOPHILUS INFLUENZAE; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; RESPIRATORY SYSTEM; STAPHYLOCOCCUS AUREUS;

EID: 33745185998     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.02.014     Document Type: Article

References (13)

1. Song J.H., Jung S.I., Ko K.S., et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP Study). Antimicrob Agents Chemother 48 (2004) 2101-2107
2. Jones R.N., Pfaller M.A., Jacobs M.R., et al. Cefditoren in vitro activity and spectrum: a review of international studies using reference methods. Diagn Microbiol Infect Dis 41 (2001) 1-14
3. Dubois J., and St-Pierre C. In vitro study of the post-antibiotic effect and the bactericidal activity of cefditoren and ten other oral antimicrobial agents against upper and lower respiratory tract pathogens. Diagn Microbiol Infect Dis 37 (2000) 187-193
4. Fuchs P.C., Barry A.L., and Brown S.D. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria. Diagn Microbiol Infect Dis 37 (2000) 265-269
5. Johnson D.M., Biedenbach D.J., Beach M.L., et al. Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species. Diagn Microbiol Infect Dis 37 (2000) 99-105
6. Karlowsky J.A., Critchley I.A., Draghi D.C., et al. Activity of cefditoren against β-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalis. Diagn Microbiol Infect Dis 42 (2002) 53-58
7. Karlowsky J.A., Jones M.E., Draghi D.C., et al. In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren. Diagn Microbiol Infect Dis 42 (2002) 59-64
8. Reinert R.R., Al-Lahham A., and Lu{combining double acute accent}tticken R. In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998. J Antimicrob Chemother 48 (2001) 279-281
9. Seki H., Kasahara Y., Ohta K., et al. Antimicrobial activities of cefditoren against respiratory pathogens isolated from children in Japan. J Infect Chemother 5 (1999) 16-20
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. CLSI/NCCLS document M100-S15 (2005), CLSI, Wayne, PA
11. Jones R.N., Biedenbach D.J., Croco M.A.T., et al. In vitro evaluation of a novel orally administered cephalosporin (cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae. Diagn Microbiol Infect Dis 31 (1998) 573-578
12. Sugita R., Deguchi K., Fujimaki Y., et al. Clinical efficacy in pediatrics sinusitis infections of cefditoren pivoxil granule therapy and its in vitro antibacterial activity against clinically isolated strains. Jpn J Antibiot 50 (1997) 727-737 [in Japanese]
13. Jones R.N., Biedenbach D.J., and Johnson D.M. Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods. Diagn Microbiol Infect Dis 37 (2000) 143-146